ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)

CAPS Rating: No stars

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Recs

1
Player Avatar kenc132000 (96.22) Submitted: 12/9/2006 8:46:17 PM : Outperform Start Price: $15.93 ZGEN.DL Score: -21.47

Stock appears to be bottoming. High potential.

Featured Broker Partners


Advertisement